Last reviewed · How we verify
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
To evaluate the efficacy, optimal dose and efficacy trend of multiple subcutaneous injections of peginterferon α1b in patients with herpes zoster, and provide support for phase III clinical trials.
Details
| Lead sponsor | Shanghai Institute Of Biological Products |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 50 |
| Start date | Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jul 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Herpes Zoster
Interventions
- Peginterferon α1b
- Peginterferon α1b with valacyclovir
- Valacyclovir
Countries
China